Head to Head Contrast: Basel Medical Group (NASDAQ:BMGL) & Viemed Healthcare (NASDAQ:VMD)

by · The Markets Daily

Viemed Healthcare (NASDAQ:VMDGet Free Report) and Basel Medical Group (NASDAQ:BMGLGet Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, valuation, analyst recommendations and earnings.

Profitability

This table compares Viemed Healthcare and Basel Medical Group’s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Viemed Healthcare4.81%10.16%7.22%
Basel Medical GroupN/AN/AN/A

Earnings and Valuation

This table compares Viemed Healthcare and Basel Medical Group”s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$270.28 million1.24$14.93 million$0.3624.44
Basel Medical Group$8.90 million0.89-$9.50 millionN/AN/A

Viemed Healthcare has higher revenue and earnings than Basel Medical Group.

Volatility and Risk

Viemed Healthcare has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, Basel Medical Group has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500.

Institutional & Insider Ownership

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.6% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Viemed Healthcare and Basel Medical Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Viemed Healthcare03102.25
Basel Medical Group10001.00

Viemed Healthcare currently has a consensus target price of $14.00, indicating a potential upside of 59.09%. Given Viemed Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe Viemed Healthcare is more favorable than Basel Medical Group.

Summary

Viemed Healthcare beats Basel Medical Group on 12 of the 12 factors compared between the two stocks.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

About Basel Medical Group

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.